Physician preferences for chemotherapy in the treatment of non-small cell lung cancer in China: evidence from multicentre discrete choice experiments.

ABSTRACT:

Objective

To evaluate physician risk-benefit preferences and trade-offs when making chemotherapy decisions for patients with non-small cell lung cancer (NSCLC).

Design

A discrete choice experiment (DCE).

Settings

Tertiary hospitals in Beijing, Shanghai, Guangzhou and Chengdu of China.

Participants

The participants were 184 physicians (mean age of 37 years) with more than 1 year of NSCLC chemotherapy practice.

Outcomes

The DCE survey was constructed by six attributes: progression-free survival (PFS), disease control rate (DCR), risk of moderate side effects, risk of severe side effects, mode of administration and out-of-pocket costs. Physicians' relative preferences and trade-offs in patient out-of-pocket costs for each attribute level were estimated usin

SUBMITTER: Sun H 

PROVIDER: S-EPMC7045216 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature